Healthcare
China dental 3D printing company raises $34m
Chinese dental 3D printing company Chamlion Technology has raised CNY 236m (USD 34m) in Series B funding from Vertex Ventures, 3H Health Investment, and Zhencheng Investment.
China's Alebund Pharma gets $145m in debt, equity funding
Alebund Pharmaceuticals has raised close to CNY 200m (USD 29m) in a pre-Series C funding round. Investors include state-owned Yangzhou Guojin Investment and Yangzhou Longchuan Holdings.
Wellington leads $150m round for Australia's Saluda Medical
Wellington Management has led a USD 150m round for Saluda Medical, an Australian devices company focused on spinal cord stimulation. TPG also came in as a new investor.
JBIC, Mitsui back Singapore's Wellesta
Japan Bank for International Cooperation (JBIC) and Mitsui & Co have invested in Singapore-based Wellesta, a diversified services provider for the regional healthcare industry.
Temasek increases holding in India's Manipal Health
Temasek Holdings is set to become the majority shareholder in Indian hospital operator Manipal Health Enterprises, having agreed to acquire an additional 41% stake in the company. The transaction facilitates an exit for TPG Capital, but the PE firm will...
China GPs re-up in ArriVent Biopharma's $155m Series B
Assorted Chinese investors have participated in a USD 155m Series B round for US-headquartered ArriVent Biopharma, which targets drug candidates emanating from emerging biotech hubs, including China.
Longreach buys Japan healthcare SaaS player
North Asia buyout specialist The Longreach Group has invested an undisclosed sum in Wellness Communications Corporation (WCC), a Japanese healthcare software-as-a-service (SaaS) provider.
TII, Premji to acquire India medical devices player
Tube Investments of India (TII) and Premji Invest have agreed to acquire medical instruments maker Lotus Surgicals for up to INR 3.5bn (USD 42.3m), providing an exit for Samara Capital.
Bain pursues buyout of Australia's Estia Health
Bain Capital has offered to acquire Australia-listed aged care provider Estia Health for AUD 775.1m (USD 517.4m).
Deal focus: India’s IIFL plans hospital expansion
India’s IIFL Asset Management is taking its private equity business deeper into healthcare with Kauvery Hospitals. The plan is to double patient capacity and IPO within three years
Deal focus: GL Capital plots careful China carve-out
GL Capital worked quietly but industriously to secure a leveraged buyout of China-based contract manufacturer Foryou Medical Devices – even using renminbi financing to avoid US dollar interest rate exposure
DEG leads round for Indonesian mRNA vaccine developer
German development finance organisation DEG has contributed USD 8m as the lead investor in a new funding round for Etana Biotechnologies Indonesia, supported by Yunfeng Capital, HighLight Capital, and East Ventures.
China cell therapy developer Neowise raises $29m
Chinese cell therapy company Neowise has raised an extended Series A round of CNY200m (USD 29m) from a group including Oriza Seed Fund Management and Marathon Venture Partners.
Heritas hits $20m first close on Asia impact fund
Singapore-based private equity firm Heritas Capital has reached a first close of USD 20m on its latest Asia impact fund against an overall target of USD 50m. DBS contributed USD 10m.
India's HealthPlix raises $22m Series C
India’s HealthPlix, a medical records platform for doctors that aims to democratize access to digital healthcare in remote areas, has raised a USD 22m Series C round led by Avataar Venture Partners.
India's Rockstud targets $37m for sophomore angel fund
India’s Rockstud Capital, an early-stage VC investor backed by high net worth individuals, has launched its second angel fund with a target of INR 3bn (USD 37m).
Kedaara buys majority stake in India dermatology player
Kedaara Capital has acquired a majority stake in medico-aesthetic dermatology services Oliva Skin & Hair Clinic, facilitating an exit for healthcare specialist InvAscent Capital.
China artificial heart developer raises $100m
China-based medical device manufacturer Evaheart has raised a Series A of close to USD 100m led by Chinese vaccine developer Sinovac.
Qiming, Ince invest in China, US biotech start-up
Qiming Venture Partners and Ince Capital have led a USD 50m Series B round for China and US-based oncology and autoimmune diseases treatments developer Allorion Therapeutics.
India's IIFL invests $70m in Kauvery hospital chain
India’s IIFL Asset Management (IIFL AM) has invested USD 70m in local hospital chain Kauvery Hospitals via its private equity unit, acquiring a minority stake.
Singapore's SeaTown backs buy-and-build healthcare platform
A fund managed by SeaTown Holdings International, an affiliate of Singapore’s Temasek Holdings, has invested SGD 150m (USD 111m) in Foundation Healthcare Holdings (FHH), a newly created private healthcare platform.
China Life, Qianhai Ark back ophthalmic device maker
China Life Private Equity and Shenzhen-based Qianhai Ark have led a CNY 300m (USD 44m) Series C round for Svision Imaging, a China-based ophthalmic device manufacturer.
Japan's Keio Innovation targets $109m for Fund III
Keio Innovation, a VC arm of Keio University, is aiming to raise JPY 15bn (USD 109.2m) for its third fund, more than its first two vintages combined.
NIC buys Japan dental consultancy, Jafco exits
Japanese private equity firm Nippon Investment Corporation (NIC) has acquired 100% of local dental industry services provider Medical Support Consulting, facilitating an exit for Jafco.